Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR.
Phase 2
Not yet recruiting
- Conditions
- Hip Prosthesis InfectionKnee Prosthesis Infection
- Interventions
- Biological: Anti-Staphylococcus aureus Bacteriophages (PP1493 and PP1815) intra-articular injection with 0.9% NaCl solutionDrug: 0.9% NaCl solution
- First Posted Date
- 2024-09-20
- Last Posted Date
- 2024-09-20
- Lead Sponsor
- Phaxiam Therapeutics
- Target Recruit Count
- 100
- Registration Number
- NCT06605651
© Copyright 2025. All Rights Reserved by MedPath